Because these inhibitors have a broad spectrum of targets, we also validated our results in our HIF-1 or EHD2 KD/KO HCC cells to demonstrate that hypoxia-induced dextran uptake was mediated through HIF-1/EHD2 pathway specifically. This evidence concerns the gene EHD2 and hepatocellular carcinoma.